期刊文献+

系统化管理在妇科肿瘤化疗所致恶心呕吐患者中的应用效果

Application Effect of Systematic Management in Chemotherapy-Induced Nausea and Vomiting in Patients with Gynecological Tumors
下载PDF
导出
摘要 目的探讨系统化管理方案在妇科肿瘤化疗所致恶心呕吐(CINV)患者中的应用效果及患者满意度。方法选取2022年1月至2023年6月收治的妇科肿瘤行化疗患者248例,按照随机抽签法分为对照组和观察组各124例。对照组实施常规管理,观察组实施系统化管理。比较2组CINV发生率、恶心、呕吐频率及程度、心理状态[状态-特质焦虑量表]、生活质量[呕吐功能性生活指数(FLIE)]、患者满意度。结果观察组CINV发生率[46.77%(58/124)]低于对照组[67.74%(84/124)](P<0.05)。观察组恶心、呕吐频率及程度均低于对照组,FLIE量表恶心、呕吐维度及总分高于对照组(P<0.01)。观察组状态焦虑量表、特质焦虑量表评分及总分均低于干预前,且观察组低于对照组(P<0.01)。观察组满意度评价量表各项评分及总分均高于对照组(P<0.01)。结论系统化管理能有效预防妇科肿瘤化疗患者CINV,减轻恶心呕吐发生频率与程度,改善患者心理状态,提高患者生活质量及满意度。 Objective To explore the application effect and patient satisfaction of systematic management plan in chemotherapy-induced nausea and vomiting(CINV)in patients with gynecological tumors.Methods A total of 248 patients with gynecological tumors undergoing chemotherapy from January 2022 to June 2023 were selected and divided into a control group(n=124)and an observation group(n=124)according to random number table method.The control group was given routine management,while the observation group was given systematic management.The incidence of CINV,frequency and degree of nausea and vomiting,psychological state[State-Trait Anxiety Inventory(STAI)],quality of life[Functional Life Index of Emesis(FLIE)],and patient satisfaction were compared between the two groups.Results The incidence of CINV in the observation group[46.77%(58/124)]was lower than that in the control group[67.74%(84/124)](P<0.05).The frequency and degree of nausea and vomiting in the observation group were lower than those in the control group,and the nausea and vomiting dimensions and total scores on the FLIE scale were higher than those in the control group(P<0.01).The scores and total scores of STAI in the observation group were lower than those before intervention,and lower in the observation group than in the control group(P<0.01).The scores and total scores of the satisfaction evaluation scale in the observation group were higher than those in the control group(P<0.01).Conclusion Systematic management can effectively prevent CINV in patients with gynecological tumors undergoing chemotherapy,reduce the frequency and severity of nausea and vomiting,improve patients'psychological state,and enhance their quality of life and satisfaction.
作者 代晟 杨冰 刘澈 DAI Sheng;YANG Bing;LIU Che(Department of Obstetrics and Gynecology,the Sixth Hospital of Beijing City,Beijing 100010,China)
出处 《临床误诊误治》 CAS 2024年第15期30-34,40,共6页 Clinical Misdiagnosis & Mistherapy
基金 2022年度首都卫生发展科研专项项目(2022-4-7014)。
关键词 宫颈肿瘤 卵巢肿瘤 化疗所致恶心呕吐 系统化管理 状态-特质焦虑量表 呕吐功能性生活指数 Cervical tumor Ovarian tumor Chemotherapy-induced nausea and vomiting Systematic management State-Trait Anxiety Inventory Functional Life Index of Emesis
  • 相关文献

参考文献12

二级参考文献111

  • 1王晖,谢红巧,王丽燕,马斌.预防性护理对腹腔镜胃肠道肿瘤手术患者下肢深静脉血栓形成的影响[J].中华肿瘤防治杂志,2020,27(S01):236-237. 被引量:7
  • 2杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 3陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 4汪向东 王希林 等.心理卫生评定量表手册(增订版)[J].中国心理卫生杂志,1999,:31-130.
  • 5NCCN Clinical Practice Guidelines in Oncology: Antiemesis. version 1. 2014[EB/OL] .[2014-02-25]. http://www. nccn. orgl professionalsl physician_glsl pdfl antiemesis. pdf.
  • 6MASCC/ESMO. Antiemetic Guidelines 2013[EB/OL].[2014- 02-25]. http://www. mascc. orgl antiemetic-guidelines; 2013 MASccTM?.
  • 7Gralla RJ, Osoba D, Krismg, et al. Recommendations for the use of anti emetics : evidence-based, clinical practice guidelines[J] .J Clin Oncol, 1999, 17(9): 2971-2994.
  • 8徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014—02-25].http://www.csao].cn/bencandy.php?aid=6246.
  • 9Apfel CC, Heidrich FM,Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting[J] . BrJ Anaesth, 2012, 109(5): 742-753.
  • 10Warr DG, Grunberg SM, Gralla RJ, et al. The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials[J]. EurJ Cancer, 2005, 41(9): 1278-1285.

共引文献503

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部